Skip to main content

Microplastics Webinar Part 2 – Continued Issues and Impact on Pharmaceutical Products










Recording from Wednesday, February 17, 2021

The European Chemicals Agency (ECHA) is moving forward with proposed restrictions on the use of microplastics in products used in various market segments – including medicinal products. ECHA’s broad definition of microplastics may impact many excipients and drug products leading to increased labeling and reporting requirements. Based on current information, it is feasible that the regulation will come into force in late 2021 or early 2022.